New paper in Value in Health (w/ Wirth, Edwards & Reeve): FDA's PFDD Guidance 3 adopts the rationale-based approach to validation for COAs. We offer two strategies and generic starting points for constructing a sound rationale for PROs, ObsROs, ClinROs, and PerfOs.
doi.org/10.1016/j.jv...